Differences

This shows you the differences between two versions of the page.

Link to this comparison view

cl:psychiatric-side-effects-of-medications [2019/04/17 10:18]
psychdb
cl:psychiatric-side-effects-of-medications [2020/04/30 22:11]
Line 1: Line 1:
-====== Psychiatric Side Effects of Medications and Substances ====== 
-===== Primer ===== 
-Medications and recreational substances can have profound psychiatric symptoms for patients. 
- 
-== Medications with Depression as a Side Effect == 
-  * [[https://​www.ncbi.nlm.nih.gov/​pmc/​articles/​PMC3181628/​|Tango,​ R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience,​ 5(2), 155.]] 
-  * [[https://​jamanetwork.com/​journals/​jama/​fullarticle/​2684607|Qato,​ D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] 
- 
- 
-===== Substance/​Medication-Induced Major or Mild Neurocognitive Disorder ===== 
-<WRAP group> 
-<WRAP half column> 
-== Criterion A == 
-The criteria are met for major or mild neurocognitive disorder. 
- 
-== Criterion B == 
-The neurocognitive impairments do not occur exclusively during the course of a delirium and persist beyond the usual duration of intoxication and acute withdrawal. 
- 
-== Criterion C == 
-The involved substance or medication and duration and extent of use are capable of producing the neurocognitive impairment. 
- 
-== Criterion D == 
-The temporal course of the neurocognitive deficits is consistent with the timing of substance or medication use and abstinence (e.g., the deficits remain stable or improve after a period of abstinence). 
- 
-</​WRAP>​ 
-<WRAP half column> 
-== Criterion E == 
-The neurocognitive disorder is not attributable to another medical condition or is not better explained by another mental disorder 
- 
-== Specifiers == 
-<​accordion collapsed="​false">​ 
-<panel icon="​fa fa-search-plus"​ size="​xs"​ title="​Substance Specifier">​ 
-  * Alcohol (major neurocognitive disorder), nonamnestic-confabulatory type 
-  * Alcohol (major neurocognitive disorder), amnestic-confabulatory type 
-  * Alcohol (mild neurocognitive disorder) 
-  * Inhalant (major neurocognitive disorder) 
-  * Inhalant (mild neurocognitive disorder) 
-  * Sedative, hypnotic, or anxiolytic (major neurocognitive disorder) 
-  * Sedative, hypnotic, or anxiolytic (mild neurocognitive disorder) 
-  * Other (or unknown) substance (major neurocognitive disorder) 
-  * Other (or unknown) substance (mild neurocognitive disorder) 
-</​panel>​ 
-<panel icon="​fa fa-search-plus"​ size="​xs"​ title="​Other Specifier">​ 
-**Specify if:** 
-  * Persistent: neurocognitive impairment continues to be significant after an extended period of abstinence. 
-</​panel>​ 
-</​accordion>​ 
-</​WRAP>​ 
-</​WRAP>​ 
-